SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052969
Filing Date
2020-11-10
Accepted
2020-11-10 16:15:43
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20200930.htm 10-Q 1698111
2 EX-10.1 rna-ex101_213.htm EX-10.1 81451
3 EX-31.1 rna-ex311_9.htm EX-31.1 10342
4 EX-31.2 rna-ex312_8.htm EX-31.2 10150
5 EX-32.1 rna-ex321_6.htm EX-32.1 6789
6 EX-32.2 rna-ex322_7.htm EX-32.2 6762
  Complete submission text file 0001564590-20-052969.txt   6116264

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rna-20200930.xml EX-101.INS 1080738
8 XBRL TAXONOMY EXTENSION SCHEMA rna-20200930.xsd EX-101.SCH 57496
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20200930_cal.xml EX-101.CAL 43778
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20200930_def.xml EX-101.DEF 181673
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20200930_lab.xml EX-101.LAB 435401
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20200930_pre.xml EX-101.PRE 334988
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 201301306
SIC: 2834 Pharmaceutical Preparations